Gender Specific Aspects of Cell Death in the Cardiovascular System
Journal:
Current Pharmaceutical Design
Volume:
17
Page:
1046-1055
Author(s):
Marina Pierdominici, Elena Ortona, Flavia Franconi, Massimiliano Caprio, Elisabetta Straface and Walter Malorni
Gender-Specific Aspects in Primary and Secondary Prevention of Cardiovascular Disease
Journal:
Current Pharmaceutical Design
Volume:
17
Page:
1082-1089
Author(s):
G. Mercuro, M. Deidda, A. Bina, E. Manconi and G. M.C. Rosano
The Effect of SEX/Gender on Cardiovascular Pharmacology
Journal:
Current Pharmaceutical Design
Volume:
17
Page:
1095-1107
Author(s):
Flavia Franconi, Ciriaco Carru, Walter Malorni, Stefano Vella and Giuseppe Mercuro
Aldose Reductase / Polyol Inhibitors for Diabetic Retinopathy
Journal:
Current Pharmaceutical Biotechnology
Volume:
12
Page:
373-385
Author(s):
Irina G. Obrosova and Peter F. Kador
Lycopene and Cardiovascular Diseases: An Update
Journal:
Current Medicinal Chemistry
Volume:
18
Page:
1146-1163
Author(s):
A. Mordente, B. Guantario, E. Meucci, A. Silvestrini, E. Lombardi, G. E. Martorana, B. Giardina and V. Bohm
NGAL is a Precocious Marker of Therapeutic Response
Journal:
Current Pharmaceutical Design
Volume:
17
Page:
844-849
Author(s):
Valeria Cernaro, Davide Bolignano, Valentina Donato, Antonio Lacquaniti, Antoine Buemi, Eleonora Crascì, Silvia Lucisano and Michele Buemi
Correlation Analysis of Capillary APOE, VEGF and eNOS Expression in Alzheimer Brains
Journal:
Current Alzheimer Research
Volume:
8
Page:
197-202
Author(s):
J. Provias and B. Jeynes
An Update on the Roles of the Complement System in Autoimmune Diseases and the Therapeutic Possibilities of Anti-Complement Agents
Journal:
Current Drug Therapy
Volume:
6
Page:
35-50
Author(s):
Masashi Mizuno and B. Paul Morgan
Etiopathogenesis, Classical Immunotherapy and Innovative Nanotherapeutics for Inflammatory Neurological Disorders
Journal:
Current Nanoscience
Volume:
7
Page:
2-20
Author(s):
Maria Jose Sa, Joana Guimaraes, Pedro Abreu, Amelia Mendes and Eliana B. Souto
Pharmacological Interventions on Asymmetric Dimethylarginine, a Clinical Marker of Vascular Disease
Journal:
Current Medicinal Chemistry
Volume:
18
Page:
714-724
Author(s):
M. Marin and S. Manez